COSMOS Pharmaceutical Corporation

Tokyo Stock Exchange 3349.T

COSMOS Pharmaceutical Corporation Current Liabilities for the year ending May 31, 2024: USD 1.36 B

COSMOS Pharmaceutical Corporation Current Liabilities is USD 1.36 B for the year ending May 31, 2024, a -1.66% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

COSMOS Pharmaceutical Corporation Current Liabilities for the year ending May 31, 2023 was USD 1.38 B, a 9.49% change year over year.
COSMOS Pharmaceutical Corporation Current Liabilities for the year ending May 31, 2022 was USD 1.26 B, a -13.53% change year over year.
COSMOS Pharmaceutical Corporation Current Liabilities for the year ending May 31, 2021 was USD 1.46 B, a -3.09% change year over year.
COSMOS Pharmaceutical Corporation Current Liabilities for the year ending May 31, 2020 was USD 1.50 B, a 22.16% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Tokyo Stock Exchange: 3349.T

COSMOS Pharmaceutical Corporation

CEO	Mr. Hideaki Yokoyama
IPO Date	Nov. 11, 2004
Location	Japan
Headquarters	Fukuoka Daiichi Building
Employees	5,512
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Specialty Retail

Description

COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.

Key trends

Past 5 years